Elio Schouppe
About Elio Schouppe
Elio Schouppe is a Medical Science Manager at Bristol-Myers Squibb, specializing in immuno-oncology and cardiovascular fields in New York, United States.
Current Position at Bristol-Myers Squibb
Elio Schouppe is currently serving as a Medical Science Manager at Bristol-Myers Squibb, a prominent biopharmaceutical company. His responsibilities include overseeing medical science projects with a particular focus on immuno-oncology. In addition, he fulfills the role of Scientific Advisor in the cardiovascular field, contributing his expertise to various initiatives within these specialized medical domains. He has been with Bristol-Myers Squibb since May 2018, operating out of their New York, New York office.
Relevant Past Experience
Before joining Bristol-Myers Squibb, Elio Schouppe held a position at BD as a Scientific Support Specialist. During his tenure from 2014 to 2015, he provided scientific support for various projects, enhancing his practical experience in medical science. Additionally, he spent five years at Vrije Universiteit Brussel as a PhD student, conducting in-depth research and contributing to academic advancements from 2008 to 2013. This robust academic and practical background has equipped him with the skills necessary for his current roles.
Educational Background
Elio Schouppe's educational foundation is rooted in his studies at Vrije Universiteit Brussel. He achieved a Master of Science, Masters, during his time at the university from 2003 to 2008. Additionally, he pursued further studies from 2009 to 2010. His comprehensive education in science has laid a strong foundation for his career in medical science management, allowing him to engage in complex scientific endeavors with confidence and expertise.
Expertise in Immuno-Oncology and Cardiovascular Fields
Elio Schouppe has extensive experience in both the immuno-oncology and cardiovascular fields. As a Medical Science Manager at Bristol-Myers Squibb, he leverages his expertise to drive scientific progress in these specialized areas. His roles involve strategic oversight and advisory functions that contribute to advancing the biopharmaceutical company's objectives in improving patient outcomes through innovative treatments in immuno-oncology and cardiovascular health.